PodParley PodParley
GPH 64: COPD and Asthma

EPISODE · Mar 27, 2026 · 54 MIN

GPH 64: COPD and Asthma

from Clinical Deep Dives · host Dr Manaan Kar Ray

Chronic respiratory diseases rarely command the urgency of pandemics or malignancy, yet they impose a vast and persistent global burden. Chronic obstructive pulmonary disease (COPD) and asthma together account for millions of deaths and even more years lived with disability.In this episode of Medlock Holmes: Global Public Health, Holmes turns to the air we breathe - and the systems that shape it.We explore:• The global burden of COPD and asthma• Tobacco as the dominant risk factor for COPD• Biomass fuel exposure and indoor air pollution• Urban air quality and environmental determinants• Occupational exposures• The inflammatory pathophysiology of asthma• Early-life determinants and developmental origins• Acute exacerbations and health system strain• Prevention through regulation and clean energy transitionCOPD often reflects decades of cumulative exposure - a slow narrowing of possibility. Asthma, by contrast, fluctuates - an episodic tightening that reveals environmental triggers and immune dysregulation.Holmes traces how respiratory disease illustrates the inseparability of clinical medicine and environmental policy. Clean air legislation, tobacco control, housing standards, and climate policy are not peripheral - they are central interventions.Breath is both biological function and political outcome.────────────────────────────Key Takeaways• COPD and asthma represent major contributors to global morbidity and mortality• Tobacco remains the primary preventable cause of COPD• Indoor biomass fuel exposure disproportionately affects low-income populations• Air pollution is a major modifiable determinant• Early-life exposures shape long-term respiratory health• Policy interventions are as important as pharmacological treatment• Climate change is likely to influence respiratory disease burden This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit drmanaankarray.substack.com/subscribe

NOW PLAYING

GPH 64: COPD and Asthma

0:00 54:38

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

Oncology Today with Dr Neil Love Research To Practice Medical oncologist Dr Neil Love interviews clinical investigators on new research and practical application to general medical oncology practice. My Take On It with Your Angelic Karma® Your Angelic Karma Here we take a look at how the United States measures alongside other First World Nations. + taking a deep dive into the science -The Report Metagenics Institute Podcast Metagenics Welcome to the Metagenics Institute Podcast where Healthcare Practitioners can hear innovative, cutting-edge information from leading experts from around the world. Join your host, Nathan Rose, to explore the latest evidence in Natural Health, challenge and debunk industry myths and offer practical, tangible, clinical tools which will transform your practice. The Syndicate Blogcast: Startups | Startup Investing | Tech News | Angel Investors | VC | Venture Capital | Private Equity | Crowdfunding | Fundraising Matt Ward - Serial Entrepreneur | Angel Investor | Startup Advisor | Amazon Ecommerce The Syndicate Blogcast show is an extension of The Syndicate podcast, featuring long form articles on the future technology, ecommerce, business and life. The mini-sodes deconstruct high level startup, business and tech issues to help investors and operators better understand and win the market. Recurring topics include: Facebook, Google, Amazon, Apple, Ecommerce, Blockchains, ICOs, Cryptocurrencies, Marketing, Fundraising, Venture Capital, Startup Challenges, Business Development and more. The Blogcast comes in addition to The Syndicate - the place where investors and startups combine to create crazy businesses and even crazier returns. The Syndicate podcast is a deep dive on the angel investors and VCs behind the big name startups. We interview the best and brightest investors, syndicate leads, GPs, limited partners and startup founders to create an original, off the cuff discussion on startup investing.
URL copied to clipboard!